PROVOST MIRIAM

PrivateCIK: 1773663
Location

ANDOVER, MA

PROVOST MIRIAM (VP of US Regulatory & FDA Rel.) sold 10.3% of their position (2.71K shares) of TRANSMEDICS GROUP, INC. on the open market

Open‑market sale worth $180.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderPROVOST MIRIAMCIK 1773663
IssuerTRANSMEDICS GROUP, INC.CIK 1756262
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
-2.71K
Net shares
Net seller
$180.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
5.48K acquired · 8.19K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+1.78K

Price / share

$3.22

Trade value

$5.75K

% of position

8.6%
8/31/2023
20.84K22.62K

Common Stock

Direct
M · Option Exercise

Shares

+3.69K

Price / share

$38.46

Trade value

$142.11K

% of position

16.3%
8/31/2023
22.62K26.32K

Common Stock

Direct
S · Sale

Shares

2.71K

Price / share

$66.52

Trade value

$180.14K

% of position

10.3%
8/31/2023
26.32K23.61K
Total

Net shares

+2.77K

Net value

-$32.28K

Derivative Transactions2

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

1.78K shares

Shares

1.78K

Strike price

3.22

Held after

16.50K

Exercisable

8/31/2023

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

3.69K shares

Shares

3.69K

Strike price

38.46

Held after

11.41K

Exercisable

8/31/2023
PROVOST MIRIAM — Insider Transaction (Form 4) Filed Sep 5, 2023 | Finecho